Nuvation Historical Financial Ratios
| NUVB Stock | USD 1.94 0.02 1.02% |
Nuvation Bio is lately reporting on over 96 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 604 will help investors to properly organize and evaluate Nuvation Bio financial condition quickly.
Nuvation |
About Nuvation Financial Ratios Analysis
Nuvation BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Nuvation Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Nuvation financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Nuvation Bio history.
Nuvation Bio Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Nuvation Bio stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nuvation Bio sales, a figure that is much harder to manipulate than other Nuvation Bio multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from Nuvation Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Nuvation Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.At present, Nuvation Bio's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's PB Ratio is expected to grow to 1.62, whereas Book Value Per Share is forecasted to decline to 1.61.
| 2024 | 2025 (projected) | Payables Turnover | 1.11 | 1.17 | Days Of Inventory On Hand | 9.3K | 8.3K |
Nuvation Bio fundamentals Correlations
Click cells to compare fundamentals
Nuvation Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nuvation Bio fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 5.31 | 2.25 | 0.64 | 0.55 | 1.54 | 1.62 | |
| Book Value Per Share | 2.21 | 3.77 | 3.02 | 2.76 | 1.73 | 1.61 | |
| Free Cash Flow Yield | (0.0321) | (0.0407) | (0.23) | (0.21) | (0.18) | (0.19) | |
| Operating Cash Flow Per Share | (0.37) | (0.34) | (0.44) | (0.31) | (0.49) | (0.51) | |
| Capex To Depreciation | 1.41 | 1.53 | 1.86 | 0.31 | 0.36 | 0.34 | |
| Pb Ratio | 5.31 | 2.25 | 0.64 | 0.55 | 1.54 | 1.62 | |
| Free Cash Flow Per Share | (0.38) | (0.35) | (0.45) | (0.31) | (0.49) | (0.51) | |
| Roic | (0.19) | (0.11) | (0.15) | (0.16) | (1.21) | (1.15) | |
| Cash Per Share | 2.21 | 3.87 | 3.05 | 2.79 | 1.87 | 1.64 | |
| Pocfratio | (31.24) | (24.67) | (4.33) | (4.86) | (5.48) | (5.76) | |
| Capex To Operating Cash Flow | (0.003969) | (0.004136) | (0.00385) | (0.001015) | (0.001242) | (0.001304) | |
| Pfcf Ratio | (31.11) | (24.57) | (4.31) | (4.86) | (5.48) | (5.75) | |
| Income Quality | 0.88 | 0.79 | 0.92 | 0.9 | 0.23 | 0.22 | |
| Roe | (0.18) | (0.11) | (0.14) | (0.13) | (1.22) | (1.16) | |
| Ev To Operating Cash Flow | (30.42) | (22.77) | (3.32) | (4.29) | (5.28) | (5.54) | |
| Pe Ratio | (28.89) | (21.1) | (4.69) | (4.36) | (1.26) | (1.32) | |
| Return On Tangible Assets | (0.18) | (0.1) | (0.13) | (0.12) | (1.06) | (1.11) | |
| Ev To Free Cash Flow | (30.3) | (22.68) | (3.31) | (4.29) | (5.27) | (5.53) | |
| Earnings Yield | (0.0346) | (0.0474) | (0.21) | (0.23) | (0.79) | (0.75) | |
| Net Debt To E B I T D A | 0.68 | 1.45 | 0.81 | 0.39 | 0.0473 | 0.0449 | |
| Current Ratio | 33.69 | 45.62 | 50.7 | 44.11 | 9.04 | 8.58 | |
| Tangible Book Value Per Share | 2.21 | 3.77 | 3.02 | 2.76 | 1.71 | 1.6 | |
| Shareholders Equity Per Share | 2.21 | 3.77 | 3.02 | 2.76 | 1.73 | 1.61 | |
| Capex Per Share | 0.001487 | 0.001425 | 0.001707 | 3.15E-4 | 6.03E-4 | 5.73E-4 | |
| Graham Net Net | 2.17 | 3.73 | 2.98 | 2.73 | 1.63 | 1.58 | |
| Enterprise Value Over E B I T D A | (25.58) | (17.38) | (2.67) | (2.93) | (1.21) | (1.27) | |
| Price Earnings Ratio | (28.89) | (21.1) | (4.69) | (4.36) | (1.26) | (1.32) | |
| Price Book Value Ratio | 5.31 | 2.25 | 0.64 | 0.55 | 1.54 | 1.62 | |
| Price To Operating Cash Flows Ratio | (31.24) | (24.67) | (4.33) | (4.86) | (5.48) | (5.76) | |
| Price To Free Cash Flows Ratio | (31.11) | (24.57) | (4.31) | (4.86) | (5.48) | (5.75) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.